Celgene (CELG) – Insiders' Blog
-
Pharma Stocks Drop After Trump Tweets Drug Prices Will 'Come Way Down!' (IBB)
-
Complete Donald Trump Stock Impact Guide
-
Biotechs Continue to Underperform (IBB)
-
Wall Street Looks to Soothe Biotech's Holiday Meltdown (GILD) (CELG) (AMGN)
-
Bears Beaten Back as Markets Wake Up to Oversold Conditions
-
Celgene (CELG) Lower; Suit Filed Over Thalidomide Patent Infringement
-
Take the Money and Run? Top 10 Q1 S&P 500 Stocks Look Ripe for Pullbacks
-
Opportunity Abounds for Celgene (CELG) in Multiple Segments - Cramer
-
Celgene (CELG) Wins FDA Approval for Pomalyst in Multiple Myeloma
-
Cantor Fitzgerald's Conviction Calls For 2013
-
Celgene (CELG), Sanofi (SNY), Stryker (SYK) Execs Charged in Insider Trading Ring
-
Celgene (CELG) Sees Volume as CEO Hugin Tells CNBC 'No Doubt, Venture Capital Drying Up'
-
While You're Busy Selling, Insiders Are Buying Like Crazy
-
Celgene (CELG) Provides Great Opportunity in Health Sector - Cramer
-
Dendreon (DNDN) 17% 4-Day Jump Raises Eyebrows; Is a Deal in the Works?
-
Genzyme (GENZ) Creeps Higher On Potential Biotech Mega-Deal
-
Wall Street Giddy About Dendreon (DNDN) After Provenge Approval; Where Are Shares Headed?
-
Color on Baird's Upgrade of Celgene (CELG)
-
Celgene (CELG) Closes Up 8.4%
-
Celgene (CELG) Jumps On Positive Barron's Article
-
The American Society of Hematology's Annual Meeting Is Moving Stocks (CELG, MLNM)
Back to CELG Stock Lookup